LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
Halozyme Therapeutics
HALO
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
YETI Holdings
YETI
Dorian LPG
LPG
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 1.60%1.27B | -8.20%884M | -28.08%589M | -18.67%3.83B | -6.15%793M | -15.96%1.25B | -21.26%963M | -28.66%819M | 34.83%4.71B | -10.39%845M |
Net income from continuing operations | -62.04%238M | -96.56%15M | -136.22%-113M | -40.67%1.64B | -38.68%260M | -39.19%627M | -43.67%436M | -40.80%312M | 114.81%2.76B | 11.29%424M |
Operating gains losses | 129.17%42M | 119.51%40M | 115.60%39M | 36.11%-651M | 68.10%-52M | 59.89%-144M | -5.67%-205M | 17.49%-250M | -352.89%-1.02B | -35.83%-163M |
Depreciation and amortization | 8.99%1.08B | 11.85%944M | 17.98%925M | 22.73%3.45B | 7.49%832M | 34.33%990M | 26.54%844M | 23.85%784M | 13.35%2.81B | 4.88%774M |
Deferred tax | ---- | ---- | ---- | -71.99%191M | ---- | ---- | ---- | ---- | 80.42%682M | ---- |
Other non cash items | 18.27%123M | 53.77%163M | -21.21%26M | 6.38%-631M | -11.76%-874M | -1.89%104M | 1,425.00%106M | 230.00%33M | 3.44%-674M | -0.26%-782M |
Change In working capital | 36.75%-210M | -25.66%-284M | -333.82%-295M | -255.56%-196M | 547.92%430M | -970.97%-332M | -927.27%-226M | -124.73%-68M | -48.15%126M | -128.15%-96M |
-Change in receivables | 59.42%110M | -4,500.00%-92M | -142.00%-42M | 55.67%-43M | 61.33%-210M | -67.45%69M | -102.99%-2M | -40.12%100M | 32.17%-97M | -223.21%-543M |
-Change in payables and accrued expense | 71.25%-23M | 30.77%34M | -43.90%46M | -133.18%-72M | 49.49%-100M | -321.05%-80M | -80.15%26M | -72.94%82M | -47.58%217M | -842.86%-198M |
-Change in other current liabilities | 7.48%-297M | 9.60%-226M | -19.60%-299M | ---- | ---- | -43.30%-321M | -13.64%-250M | -28.21%-250M | ---- | ---- |
-Change in other working capital | ---- | ---- | ---- | -1,450.00%-81M | ---- | ---- | ---- | ---- | 121.43%6M | ---- |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 1.60%1.27B | -8.20%884M | -28.08%589M | -18.67%3.83B | -6.15%793M | -15.96%1.25B | -21.26%963M | -28.66%819M | 34.83%4.71B | -10.39%845M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 91.78%-141M | 70.67%-1.04B | 9.54%-1.52B | -70.88%-7.35B | 42.46%-416M | -683.67%-1.72B | -30.72%-3.54B | -44.03%-1.68B | 31.83%-4.3B | 47.42%-723M |
Net PPE purchase and sale | 95.88%-69M | 69.06%-1.04B | 7.13%-1.52B | -70.78%-7.06B | 44.73%-372M | -671.33%-1.67B | -29.39%-3.37B | -42.94%-1.64B | 32.11%-4.13B | 48.11%-673M |
Net investment purchase and sale | -250.00%-84M | 104.35%6M | 117.65%6M | -75.37%-235M | 18.75%-39M | -142.11%-24M | -33.98%-138M | 15.00%-34M | 23.43%-134M | 2.04%-48M |
Net other investing changes | 166.67%12M | ---- | ---- | -64.71%-56M | 91.23%-5M | -1,700.00%-18M | -3,100.00%-30M | -113.04%-3M | 26.09%-34M | -96.55%-57M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 91.78%-141M | 70.67%-1.04B | 9.54%-1.52B | -70.88%-7.35B | 42.46%-416M | -683.67%-1.72B | -30.72%-3.54B | -44.03%-1.68B | 31.83%-4.3B | 47.42%-723M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -310.74%-1.08B | -94.70%139M | 6.66%897M | 1,073.89%3.51B | -112.61%-472M | 129.77%512M | 69.14%2.63B | 2,703.33%841M | -113.40%-360M | -303.67%-222M |
Net issuance payments of debt | -203.53%-1.06B | -94.66%149M | 5.85%959M | 64.63%4.88B | -69.83%162M | 210.39%1.02B | 38.60%2.79B | -32.24%906M | -28.74%2.96B | -8.36%537M |
Net common stock issuance | 98.16%-9M | 99.33%-1M | 70.59%-15M | 71.43%-951M | 65.43%-261M | 40.68%-490M | 66.82%-149M | 96.07%-51M | -128.01%-3.33B | -63.07%-755M |
Cash dividends paid | ---- | ---- | ---- | ---355M | ---- | ---- | ---- | ---- | --0 | ---- |
Net other financing activities | 22.22%-14M | 43.75%-9M | -235.71%-47M | -1,200.00%-66M | -350.00%-18M | -160.00%-18M | -33.33%-16M | -75.00%-14M | 154.55%6M | 71.43%-4M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -310.74%-1.08B | -94.70%139M | 6.66%897M | 1,073.89%3.51B | -112.61%-472M | 129.77%512M | 69.14%2.63B | 2,703.33%841M | -113.40%-360M | -303.67%-222M |
Net cash flow | ||||||||||
Beginning cash position | -14.52%583M | -4.77%599M | 0.31%644M | 2.56%642M | 0.00%721M | -0.29%682M | -1.26%629M | 2.56%642M | -18.17%626M | -23.70%721M |
Current changes in cash | 8.16%53M | -126.92%-14M | -77.78%-32M | -125.00%-12M | 5.00%-95M | -24.62%49M | -25.71%52M | -238.46%-18M | 137.50%48M | 69.04%-100M |
Effect of exchange rate changes | 230.00%13M | -300.00%-2M | -360.00%-13M | 143.75%14M | -14.29%18M | 64.29%-10M | 104.35%1M | 350.00%5M | -190.91%-32M | 425.00%21M |
End cash Position | -9.99%649M | -14.52%583M | -4.77%599M | 0.31%644M | 0.31%644M | 0.00%721M | -0.29%682M | -1.26%629M | 2.56%642M | 2.56%642M |
Free cash flow | 99.14%-22M | 51.82%-1.98B | -14.17%-3.55B | -92.87%-11.63B | -2.74%-1.88B | -1,008.70%-2.55B | -73.83%-4.1B | -92.14%-3.11B | 9.61%-6.03B | -62.89%-1.83B |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |